Ten months after the first patient was diagnosed with #COVID19 in the US, 8.6 million infections and 220K deaths later, how close are we to an efficacious and safe therapy? This thread looks at the science behind #Leronlimab (aka PRO-140). @CytoDyn@leronlimab 1/ pic.twitter.com/59sLLth8ze